Drug company gives ofatumumab update
Drug company gives ofatumumab update
Biotech firm Genmab has announced an update on development plans for ofatumumab in autoimmune indications focusing on relapsing multiple sclerosis following the transfer of the rights to ofatumumab from GlaxoSmithKline (GSK) to Novartis at the end of 2015...Read more - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1323 Views
-
Last post by frodo
-
- 0 Replies
- 978 Views
-
Last post by frodo
-
- 0 Replies
- 2304 Views
-
Last post by NHE
-
- 0 Replies
- 1277 Views
-
Last post by frodo
-
- 0 Replies
- 1238 Views
-
Last post by frodo
-
- 0 Replies
- 1204 Views
-
Last post by frodo
-
- 0 Replies
- 1467 Views
-
Last post by NHE
-
- 0 Replies
- 470 Views
-
Last post by NHE
-
- 1 Replies
- 2919 Views
-
Last post by Tif